3TC · DIN 02192691 · 10 mg/mL · oral liquid
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
3TC · DIN 02192691
Manufacturer: ViiV Healthcare ULC; listing date 1996-10-01
Health Canada: Marketed since 2014-01-31 · brand 3TC · ATC J05AF05 LAMIVUDINE · form Solution · route Oral · ingredients LAMIVUDINE 10 MG/ML · company Viiv healthcare ulc · schedule Prescription
3TC: Formulary list price $0.43 per unit (the source does not state the unit; exact figure $0.4344). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02192691)
Source record
DIN 02192691: 3TC
Raw flags: sec3=Y
Item: 081800005; group id 92; item number 0163; lccId None; manufacturer id VIH
Source form: O/L; strength: 10mg/mL
Recorded listing: General benefit
Source prices (unrounded): $0.4344; ministry $0.4344
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02192691
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19615
Therapeutic Notes (formulary)
Reimbursement will not be provided for the treatment of hepatitis.
Shortage status: not checked (no credentials)